| Serial Number | 88659971 |
| Word Mark | OPDIVO ALLAYZ |
| Filing Date | Friday, October 18, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 24, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 27, 2021 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 22, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Monday, January 24, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, January 24, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, June 22, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 27, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 27, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 7, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, March 22, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 1, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 1, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 1, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 1, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 17, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 17, 2020 | FINAL REFUSAL E-MAILED |
| Monday, August 17, 2020 | FINAL REFUSAL WRITTEN |
| Monday, July 27, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, July 26, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, July 26, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 29, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, January 24, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, October 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |